AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (2.5 MB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Research Article | Open Access

Aggregation of Gold Nanoparticles for Spectrophotometric Determination of Bisoprolol Hemifumarate, Buspirone HCl and Doxazosin Mesylate

Magda Mohamed AyadHisham Ezzat AbdellatefMervat Mohamed HosnyNaglaa Abdel-Sattar Kabil( )
Analytical Chemistry Department, Faculty of Pharmacy, Zagazig University, Zagazig, Egypt
Show Author Information

Abstract

A simple, rapid and sensitive spectrophotometric method was developed for determination of bisoprolol hemifumarate, buspirone HCl and doxazosin mesylate in pure form and in pharmaceutical formulations. The method was based on aggregation of synthesized gold nanoparticles (Au NPs). Gold nanoparticles showed an absorption band at 520 nm. Upon interaction with the cited drugs, the band at 520 nm disappeared with formation of a new red shifted band at 616, 656 and 670 nm for doxazosin mesylate, bisoprolol hemifumarate and buspirone HCl, respectively. Different experimental factors were optimized for higher sensitivity. The calibration curves were linear with concentrations of 3-14, 0.1-1.2 and 0.2-1.0 μg/mL for bisoprolol hemifumarate, buspirone HCl and doxazosin mesylate, respectively. The method was applied successfully to determine the studied drugs in minor concentrations in pure form and in their pharmaceutical dosage forms.

References

[1]
S.C. Sweetman, Martindale - The complete drug reference. 35 ed. The Pharmaceutical Press, 2009: 1234 (a), 965 (b) and 1275 (c).
[2]
R. Gaur, M. Azizi, J. Gan, et al., The British pharmacopoeia. Vol. Ⅱ, Ⅲ. Her Majesty's Stationery Office, 2009: 738 (a), 836 (b) and 2119 (c).
[3]
R. Ravichandran, United States Pharmacopoeia, ⅩⅩⅣ. United States Pharmacopoeia Convention, 2007: 609 (a), 742 (b) and 2119 (c).
[4]

G, Tuljarani, D.G. Sankar, P. Kadgapathi, et al., Quantitative determination of bisoprolol fumarate in bulk and pharmaceutical dosage forms by spectrophotometry. International Journal of Chemical Science, 2010, 8: 2253-2258.

[5]

R. Sahu, V.B. Patel, Simultaneous spectrophotometric estimation of hydrochlorothiazide and bisoprolol fumarate in combined dosage form. Indian Journal of Pharmaceutical Science, 2006, 68: 764-767.

[6]

A.A. Shirkhedkar, R.R. Thorve, and S.J. Surana, Simultaneous spectrophotometric estimation of bisoprolol fumarate and hydrochlorothiazide in tablet dosage form. Pakistan Journal of Pharmaceutical Science, 2008, 21: 366-369.

[7]

L. Zhang, X. Su, C. Zhang, et al., Extraction and preconcentration of β-blockers in human urine for analysis with high performance liquid chromatography by means of carrier mediated liquid phase microextraction. Talanta, 2010, 82: 984-992.

[8]

L. Ding, X. Zhou, X. Guo, et al., LC-ESI-MS method for determination of bisoprolol in human plasma. Journal of Pharmaceutical and Biomedical Analysis, 2007, 44: 520-525.

[9]

R.N. Goyal, A. Tyagi, N. Bachheti, et al., Voltammetric determination of bisoprolol fumarate in pharmaceutical formulations and urine using single-wall carbin nanotubes modified glassy carbon electrode. Electrochim. Acta., 2008, 53: 2802-2808.

[10]

R. Gannu, S.K. Yamsani, C.R. Palem, et al., Development of high performance liquid chromatography method for buspirone in rabbit serum: Application to pharmacokinetic study. Analytica Chimica Acta., 2009, 647: 226-230.

[11]

K. Jose, K. Thomas, W. Helen, et al., Simple spectrofluorimetric determination of buspirone hydrochloride in bulk drug and pharmaceutical dosage forms. Hygeia: Journal for Drugs and Medicines, 2012, 4: 6-14.

[12]

R.M. Youssef, E.F. Khamis, A.A. Gazy, et al., Assay of buspirone hydrochloride in tablets using kinetic spectrophotometry. Electrophoresis, 2006, 11: 12.

[13]

M. Zayed, A.A. El-Habeeb, Spectroscopic study of the reaction mechanism of buspirone interaction with iodine and tetracyanoethylene reagents and its applications. Drug Test and Analysis, 2009, 1: 267-274.

[14]

J. Kurien, T. Kurian, and A. Mathew, Simple spectrophotometric determination of buspirone hydrochloride in bulk drug and pharmaceutical dosage forms. Science & Society, 2012, 10: 147.

[15]

L.I. Bebawy, A.A. Moustafa, and N.F. Abo-Talib, Stability-indicating methods for the determination of doxazosin mezylate and celecoxib. Journal of Pharmaceutical and Biomedical Analysis, 2002, 27: 779-793.

[16]

S.S. Hashmi, K.P. Channabasavaraj, Y.N. Manohara, et al., Extractive spectrophotometric determination of doxazosin mesylate. International Journal of Chemical Sciences, 2007, 5: 2285-2290.

[17]

Z. Aydodmup, A. Barla, Spectrophotometric determination of doxazosin mesylate in tablets by ion-pair and charge-transfer complexation reactions. Journal of AOAC International, 2009, 92: 131-137.

[18]

Y.J. Kim, Y. Lee, M.J. Kang, et al., High-performance liquid chromatographic determination of doxazosin in human plasma for bioequivalance study of controlled release doxazosin tablets. Biomedical Chromatography, 2006, 20: 1172-1177.

[19]

R.N. Rao, D. Nagaraju, A.K. Das, et al., Separation, characterization, and quantitation of process-related substances of the anti-hypertensive drug doxazosin mesylate by reversed-phase LC with PDA and ESI-MS as detectors. Journal of Chromatographic Science, 2007, 45: 63-69.

[20]

M. Erceg, M. Cindric, L.P. Frketic, et al., A LC-MS-MS method for determination of low doxazosin concentrations in plasma after oral administration to dogs. Journal of Chromatographic Science, 2010, 48: 114-119.

[21]

A. Arranz, S. Fernandez-de-Betono, J.M. Moreda, et al., Cathodic stripping voltammetric determination of doxazosin in urine and pharmaceutical tablets using carbon paste electrodes. Analyst, 1997, 122: 849-854.

[22]

W. Gao, Y. Chen, S. Xiao et al., Hydrogen-bonding recognition- induced colorimetric determination of hydrazine based on the tryptophan capped gold nanoparticles. Journal of spectroscopy, 2013: 1-7.

[23]

V.V. Apyari, V.V. Arkhipova, S.G. Dmitrienko, et al., Using gold nanoparticles in spectrophotometry. Journal of Analytical Chemistry, 2014, 69: 1-11.

[24]
Z. Michael, Determination of thiamine in solution by UV-Visible spectrophotometry: The effect of interactions with gold nanoparticles. Thesis submitted to the Department of Chemistry, Eastern Michigan University, in partial fulfillment of requirements for the degree of Master of Science in chemistry, 2014
[25]

X. Qin, D. Shi, J. Gen-di, et al., Determination of acetamiprid by a colorimetric method based on the aggregation of gold nanoparticles. Microchim Acta, 2011, 173: 323-329.

[26]

M.R. Hormozi-Nezhad, E. Seyedhosseini, and H. Robatjazi, Spectrophotometric determination of glutathione and cysteine based on aggregation of colloidal gold nanoparticles. Scientia Iranica F. , 2012, 193: 958-963.

[27]
Citrate synthesis of gold nanoparticles. Mrsec Education Group, <http://education.mrsec.wisc.edu/277.htm>, retrived on Sep. 25, 2017.
[28]
[29]
[30]
ICH Expert Working Group, ICH Harmonized Tripartite Guidelines: Validation of Analytical Procedures: Text and Methodology Q2 (R1), Current Step 4 version. Parent Guideline dated 27 October 1994 (Complementary Guideline on Methodology dated 6 November 1996 incorporated in November 2005). Retrieved from http://www.gmp-compliance.org/guidemgr/files/Q2(R1).PDF.
[31]
J.N. Miller, J.C. Miller, Statistics and chemometrics for analytical chemistry, 6th ed. Pearson Education Limited, Harlow, 2010.
Nano Biomedicine and Engineering
Pages 1-10
Cite this article:
Ayad MM, Abdellatef HE, Hosny MM, et al. Aggregation of Gold Nanoparticles for Spectrophotometric Determination of Bisoprolol Hemifumarate, Buspirone HCl and Doxazosin Mesylate. Nano Biomedicine and Engineering, 2019, 11(1): 1-10. https://doi.org/10.5101/nbe.v11i1.p1-10

502

Views

38

Downloads

3

Crossref

5

Scopus

Altmetrics

Received: 02 April 2018
Accepted: 11 September 2018
Published: 03 January 2019
© Magda Mohamed Ayad, Hisham Ezzat Abdellatef, Mervat Mohamed Hosny, and Naglaa AbdelSattar Kabil.

This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Return